Kang-Chieh Huang

Applying iPSC to solve Neurodegeneration

Role
Scientist- Ipsc Technologies at Denali Therapeutics
Location
South San Francisco, CA, US
LinkedIn followers
500 followers

About Kang-Chieh Huang

I am an innovative driven stem cell scientist with deep expertise in developing iPSC-derived in vitro models to study neurodegenerative diseases. Currently leading efforts at Denali Therapeutics to incorporating iPSC-derived microglia, astrocyte, and neurons for target discovery screening. Proven track record in CRISPR/Cas9 genome editing, single-cell omics, and high-throughput image-based screening using automated platforms. Passionate about bridging discovery and translation, with 17 publications (8 first-author). Committed to applying human-relevant models to uncover therapeutic mechanisms and accelerate drug development for neurological disorders.(Google Scholar: & hl=en)Feel free to reach out to me at k••••••••@gmail.com.

Experience

  1. Scientist- Ipsc Technologies

    Denali Therapeutics

    Nov 2024 — Present · South San Francisco, CA, US

Education

  • Kaohsiung Medical University

    Bachelor's degree, Biomedical Science and Environmental Biology

    2009 — 2013

  • National Yang Ming University

    Master's degree, Institute of Anatomy and Cell Biology

    2013 — 2015

  • Indiana University Indianapolis

    Doctor of Philosophy - PhD, Biology

    2018 — 2023

Skills

  • Microsoft Office
  • Retinal Biology
  • Immunofluorescence
  • Histology
  • Molecular Biology
  • Immunology
  • Microsoft Word

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Kang-Chieh Huang — Scientist- Ipsc Technologies at Denali Therapeutics in South San Francisco, CA, US | Unifers